肿瘤坏死因子受体相关因子的研究进展(5)
[23] Cao Z，Xiong J，Takeuchi M，et al. TRAF6 is a signal transducer for interleukin-1 [J]. Nature，1996，383(6599)：3-6.
[24] Elinav E，Strowig T，Henao-Mejia J，et al. Regulation of the antimicrobial response by NLR proteins [J]. Immunity，2011，34(5)：65-79.
[25] Kersse K，Bertrand MJ，Lamkanfi M，et al. NOD-like receptors and the innate immune system：coping with danger，damage and death [J]. Cytokine Growth Factor Rev，2011，22(5/6)：57-76.
[26] Abbott DW，Yang Y，Hutti JE，et al. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains[J].Mol Cell Biol，2007，27(17)：12-25.
[27] Missiou A，Rudolf P，Stachon P，et al. TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation [J]. Circ Res，2010，107(6)：57-66.
[28] Gao，L，Wang PX，Zhang Y，et al. Tumor necrosis factor receptor-associated factor 5(Traf5)acts as an essential negative regulator of hepatic steatosis [J]. J Hepatol，2016， 65(1)：25-36.
[29] Chen Z，Sheng L，Shen H，et al. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses [J]. Diabetes，2012，61(3)：66-73.
[30] Xie P. TRAF molecules in cell signaling and in human diseases [J]. J Mol Signal，2013，8(1)：7.
(收稿日期：2016-12-30 本文編辑：张瑜杰), 百拇医药(金虹 李竞 高凌)
[24] Elinav E，Strowig T，Henao-Mejia J，et al. Regulation of the antimicrobial response by NLR proteins [J]. Immunity，2011，34(5)：65-79.
[25] Kersse K，Bertrand MJ，Lamkanfi M，et al. NOD-like receptors and the innate immune system：coping with danger，damage and death [J]. Cytokine Growth Factor Rev，2011，22(5/6)：57-76.
[26] Abbott DW，Yang Y，Hutti JE，et al. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains[J].Mol Cell Biol，2007，27(17)：12-25.
[27] Missiou A，Rudolf P，Stachon P，et al. TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation [J]. Circ Res，2010，107(6)：57-66.
[28] Gao，L，Wang PX，Zhang Y，et al. Tumor necrosis factor receptor-associated factor 5(Traf5)acts as an essential negative regulator of hepatic steatosis [J]. J Hepatol，2016， 65(1)：25-36.
[29] Chen Z，Sheng L，Shen H，et al. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses [J]. Diabetes，2012，61(3)：66-73.
[30] Xie P. TRAF molecules in cell signaling and in human diseases [J]. J Mol Signal，2013，8(1)：7.
(收稿日期：2016-12-30 本文編辑：张瑜杰), 百拇医药(金虹 李竞 高凌)